Pituitary Tumor Clinical Trials

44 clinical trials for Pituitary Tumor across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• NET-TIME: Inflammatory Tumor Microenvironment in Pituitary Neoplasm — RECRUITING
• Pituitary Tumor Surveillance: Pathogenic Correlation — RECRUITING
• Evaluation of the CONVIVO System — RECRUITING · NA
• Differential Study of Invasive Pituitary Adenomas in the Sellar and Cavernous Sinus Regions — RECRUITING
• Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients — RECRUITING
• Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery — RECRUITING · NA
• Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors — NOT_YET_RECRUITING
• Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors — COMPLETED · PHASE2
• Long-Term Longitudinal QoL in Patients Undergoing EEA — ACTIVE_NOT_RECRUITING
• The PROMISE Survey — ACTIVE_NOT_RECRUITING
• Validation of a Quality of Life Metric "Prolac-10" — TERMINATED
• Nasal Packing Following Endoscopic Endonasal Pituitary Resection — COMPLETED · NA
• Surgical and Pharmacological Efficacy of Knosp Grade 0-2 Prolactinoma — NOT_YET_RECRUITING · NA
• Hyponatremia Study (Delayed Hyponatremia After Pituitary Surgery) — COMPLETED · NA
• Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage — OTHER · NA
• Prospective Study of Clinically Nonfunctioning Pituitary Adenomas — COMPLETED
• To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery — OTHER
• Detection of PitNET Tissue During TSS Using Bevacizumab-800CW — COMPLETED · PHASE1
• Electrophysiology of the Human Pituitary Gland — TERMINATED · NA
• Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery — COMPLETED
• Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery — WITHDRAWN · PHASE2
• Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors — COMPLETED · PHASE4
• Epidemiology of Pituitary Tumours: Prevalence of Associated Neoplasia — OTHER
• Setting Benchmarks for Transsphenoidal Resection of Pituitary Adenomas — OTHER
• Construction and Application of a Risk Prediction Model Forepistaxis After Pituitary Tumor Resection — OTHER
• Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors — TERMINATED · PHASE2
• The Impact of Endoscopic Pituitary Surgery on Nasal Function — OTHER
• Effects of Total Intravenous Anesthesia With Propofol-remifentanil Versus Inhalational Anesthesia With Sevoflurane on Quality of Recovery in Patients Undergoing Transsphenoidal Surgery for Pituitary Tumor — COMPLETED · NA
• The TMS Treatment for Postoperative Headache in GH Tumor — OTHER · NA
• Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma — OTHER · NA
• Seoul National University Pituitary Disease Cohort Study — OTHER
• Nasal Irrigation Apply in Patients After Transsphenoidal Pituitary Tumor Resection — OTHER · NA
• Impact of Nasoseptal Flap Harvest Technique on Olfaction Following Endoscopic Transsphenoidal Pituitary Surgery — OTHER · NA
• Comparison of Propofol Requirement Between Patients With Pituitary Somatotroph Tumor and With Nonfunctioning Pituitary Tumor in Transsphenoidal Pituitary Surgery Under Total Intravenous Anesthesia — COMPLETED
• Postoperative Cognitive Dysfunction in Patients Undergoing Pituitary Removal Surgery — OTHER
• Visual Outcome After Transsphenoidal Surgery for Pituitary Macroadenoma — COMPLETED
• A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas — OTHER · NA
• Comparative Low and High Dose of Dexmedethomidine in Pituitary Tumor Removal by Transphenoid Approach — OTHER · PHASE4
• PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon — OTHER
• The Observational Study of Growth Hormone-secreting Pituitary Tumors — OTHER
• Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy — WITHDRAWN · PHASE2
• Characterization of Receptors in Non-functioning Pituitary Macroadenomas — OTHER
• Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas — TERMINATED
• Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma — OTHER

Refine this search